A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma (Q24607479)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma |
scientific article |
Statements
A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma (English)
0 references
February 2011
0 references
25
0 references
341-7
0 references
2
0 references
1 reference
1 reference
1 reference